Dr. Petrossian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Port Washington Blvd.
Ste-04
Roslyn, NY 11576Phone+1 516-414-3000Fax+1 516-414-3091
Summary
- Dr. George Petrossian is a cardiologist in East Hills, NY and is affiliated with multiple hospitals in the area, including Mount Sinai South Nassau, St. Francis Hospital, The Heart Center . He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 30 years. He specializes general interventional cardiology, carotid and vascular stenting, TAVR, Mitra clip and TMVR research trials as well as Watchman /Lariat procedures.
Education & Training
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 1989 - 1990
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 1987 - 1989
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1983 - 1987
- Icahn School of Medicine at Mount SinaiClass of 1983
Certifications & Licensure
- NJ State Medical License 1990 - Present
- NY State Medical License 1984 - 2025
- OH State Medical License 2001 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Newsday - Top Doctors on Long Island Castle Connolly, 2010-2014
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
- Join now to see all
Publications & Presentations
PubMed
- Transcatheter Aortic Valve Replacement With the Evolut FX Self-Expanding Versus SAPIEN 3 Ultra Resilia Balloon-Expandable Valves.Ali H Dakroub, Sarah Malik, Stephanie L Sellers, David Meier, Lindsey Hart
Circulation. Cardiovascular Interventions. 2024-12-01 - 1-Year Real-World Outcomes of TAVR With the Fifth-Generation Balloon-Expandable Valve in the United States.Annapoorna S Kini, Gilbert H L Tang, Ricardo Yaryura, George Petrossian, David K Roberts
JACC. Cardiovascular Interventions. 2024-11-24 - 4 citationsUse and performance of the evolut FX transcatheter aortic valve system.Tanvir Bajwa, Guilherme F Attizzani, Hemal Gada, Stanley J Chetcuti, Mathew R Williams
Cardiovascular Revascularization Medicine. 2024-10-01
Journal Articles
- Original Investigation Self-Expanding Transcatheter Aortic Valve Replacement or Surgical Valve Replacement in High-Risk Patients: 5-Year OutcomesG Michael Deeb, Steven J Yakubov, Joon S Lee, Thomas G Gleason, William Merhi, George Petrossian, G Chad Hughes, David H Adams, Neal S Kleiman, Jeffrey J Popma, Mubash..., ScienceDirect
Press Mentions
- St. Francis Only L.I. Hospital in Heart Valve Clinical TrialNovember 6th, 2021
- Study Shows TAVR Is Effective Option for Low-Risk Patients with Severe Aortic Valve StenosisMarch 18th, 2019
- Study Shows TAVR Is Effective Option for Low-Risk Patients with Severe Aortic Valve StenosisMarch 18th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: